Author: "Cocco, E." - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Cocco, E."' showing total 961 results

Start Over Author "Cocco, E."

961 results on '"Cocco, E."'

151. Divergent action of cobalt salts on the fate of peripheral blood monocytes and T lymphocytes

Author: Paladini, Fabiana, Potolicchio, I, Cocco, E, Fazegasova, H, Lombardi, G, and Sorrentino, Rosa
Published: 2006

152. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity

Author: Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, and Miterski B
Subjects: MSSS, MS, EDSS
Abstract: BACKGROUND: There is no consensus method for determining progression of disability in patients with multiple sclerosis (MS) when each patient has had only a single assessment in the course of the disease. METHODS: Using data from two large longitudinal databases, the authors tested whether cross-sectional disability assessments are representative of disease severity as a whole. An algorithm, the Multiple Sclerosis Severity Score (MSSS), which relates scores on the Expanded Disability Status Scale (EDSS) to the distribution of disability in patients with comparable disease durations, was devised and then applied to a collection of 9,892 patients from 11 countries to create the Global MSSS. In order to compare different methods of detecting such effects the authors simulated the effects of a genetic factor on disability. RESULTS: Cross-sectional EDSS measurements made after the first year were representative of overall disease severity. The MSSS was more powerful than the other methods the authors tested for detecting different rates of disease progression. CONCLUSION: The Multiple Sclerosis Severity Score (MSSS) is a powerful method for comparing disease progression using single assessment data. The Global MSSS can be used as a reference table for future disability comparisons. While useful for comparing groups of patients, disease fluctuation precludes its use as a predictor of future disability in an individual.
Published: 2005

153. Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination

Author: Franciotta, D., Avolio, C., Capello, E., Lolli, F., Aini Participating Members, M. Trojano, Leante, R., Falcone, M., Marrosu, M., Costa, G., MURRU, MR, Cocco, E., Gall, E., Chicchi, A., Maimone, D., Cuccia, S., Alessandra Lugaresi, Pantalone, A., Paolino, E., Castellazzi, M., Zaffaroni, M., Villa, C., Giunti, D., Panarese, C., Ribizzi, G., Vita, G., AGUENNOUZ, Ciranni, Am, Salmaggi, A., Bernardi, G., Ciusani, E., Passerini, G., Nobile-Orazio, E., Carpo, M., Allaria, S., Merelli, E., Bedin, R., Bertolotto, A., Sala, A., Gallo, P., Zardini, E., Andreoni, L., Siciliano, G., Bacci, A., Meucci, G., Simone, P., Desina, G., P DI VIESTI, Apollo, F., Sotgiu, S., Deiana, G., Annunziata, P., Morucci, A., Bonetti, B., Alberti, D., D FRANCIOTTA, C AVOLIO, E CAPELLO, F LOLLI, AINI PARTICIPATING MEMBERS M TROJANO, R LEANTE, M FALCONE, M MARROSU, G COSTA, MR MURRU, E COCCO, E GALL, A CHICCHI, D MAIMONE, S CUCCIA, A. LUGARESI, A PANTALONE, E PAOLINO, M CASTELLAZZI, M ZAFFARONI, C VILLA, D GIUNTI, C PANARESE, G RIBIZZI, G VITA, AGUENNOUZ, AM CIRANNI, A SALMAGGI, G BERNARDI, E CIUSANI, G PASSERINI, E NOBILE-ORAZIO, M CARPO, S ALLARIA, E MERELLI, R BEDIN, A BERTOLOTTO, A SALA, P GALLO, E ZARDINI, L ANDREONI, G SICILIANO, A BACCI, G MEUCCI, P SIMONE, G DESINA, P DI VIESTI, F APOLLO, S SOTGIU, G DEIANA, P ANNUNZIATA, A MORUCCI, B BONETTI, and D ALBERTI
Subjects: Oligoclonal bands, Standardization, MEDLINE, neuroimmunology, methods, standardization, consensus, Certification, Antibodies, NO, Multiple sclerosis, Resource (project management), Medicine, Animals, Humans, Antigens, Diagnostics, Cerebrospinal Fluid, Medical education, business.industry, Immunochemistry, Cerebrospinal fluid examination, Guideline, Joint research, Laboratory standardization, Neurology, Immunoglobulin G, Neurology (clinical), business, Neuroscience, Isoelectric focusing, Cerebrospinal fluid, Neurological diseases
Abstract: In 2002–2003, the Italian Association for Neuroimmunology (AINI) ran a program for procedure and method standardization in neuroimmunology. The main purposes of the program were: a) to improve the overall quality of analytical performance and, simultaneously, to reduce costs by resource optimization; b) to establish the bases for clinical guidelines in neurology; c) to promote the formation of laboratory networks and of joint research projects; d) to facilitate the procedures for certification required by governmental/non-governmental agencies. This report summarizes the consensus recommendations of a panel of AINI neuroimmunologists/biochemists involved in the field of cerebrospinal fluid examination. The collection process for said recommendations was guided by ‘‘impact-factored’’ literature and the knowledge of the experts involved. Communication was by email and face-to-face at two dedicated AINI workshops.
Published: 2005

154. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study

Author: Solaro, C, Brichetto, G, Amato, Mp, Cocco, E, Colombo, B, D'Aleo, G, Gasperini, C, Ghezzi, A, Martinelli, V, Milanese, C, Patti, F, Trojano, M, Verdun, E, and Mancardi, GIOVANNI LUIGI
Published: 2004

155. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study

Author: Solaro, C., Brichetto, G., Amato, M. P., Cocco, E., Colombo, B., D Aleo, G., claudio gasperini, Ghezzi, A., Martinelli, V., Milanese, C., Patti, F., Trojano, M., Verdun, E., Mancardi, G. L., Annunziata, P., Baldini, S., Zaffaroni, M., Bertolotto, A., Bonavita, S., Bramanti, P., Sessa, E., Fiorilla, T., Fuiani, A., Mazzoni, M., Mendozzi, L., Merelli, E., Sola, P., Pozzilli, C., Pucci, E., Pugliatti, M., Scandellari, C., Tola, M. R., Uccelli, A., and Murialdo, A.
Subjects: Adult, Male, medicine.medical_specialty, Spasm, Multiple Sclerosis, Adolescent, Cross-sectional study, Pain, Disease course, Central nervous system disease, Trigeminal neuralgia, Internal medicine, Surveys and Questionnaires, Back pain, medicine, Prevalence, Humans, Aged, Analgesics, Expanded Disability Status Scale, business.industry, Multiple sclerosis, Middle Aged, Trigeminal Neuralgia, medicine.disease, Tonic spasms, Cross-Sectional Studies, Italy, Back Pain, Physical therapy, Female, Neurology (clinical), medicine.symptom, business
Abstract: In a multicenter cross-sectional study, the authors assessed pain in patients with multiple sclerosis (MS) using a symptom-oriented approach. Out of 2,077 questionnaires, we used 1,672 for data analysis. Pain and frequencies included trigeminal neuralgia 2%, Lhermitte's sign 9%, dysesthetic pain 18.1%, back pain 16.4%, and painful tonic spasms 11%. Comparison between different groups showed significant differences for age, Expanded Disability Status Scale, disease duration, and disease course, but not for sex. This study underlines the relevance of pain in the clinical history of MS.
Published: 2004

156. Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo

Author: Schwab, C L, primary, Bellone, S, additional, English, D P, additional, Roque, D M, additional, Lopez, S, additional, Cocco, E, additional, Nicoletti, R, additional, Bortolomai, I, additional, Bonazzoli, E, additional, Ratner, E, additional, Silasi, D-A, additional, Azodi, M, additional, Schwartz, P E, additional, Rutherford, T J, additional, and Santin, A D, additional
Published: 2014
Full Text: View/download PDF

157. 378 - Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy

Author: Scaltriti, M., Carmona, F.J., Toska, E., Cocco, E., Hyman, D., Cutler, R., Avogadri-Connors, F., Wick, M.J., Papadopoulos, K.P., Lalani, A.S., and Baselga, J.
Published: 2016
Full Text: View/download PDF

158. The influence of index multiple sclerosis (MS) age at onset on the probability of having affected relatives

Author: Liguori, M, Paolicelli, D, Pugliatti, Maura, Cocco, E, Marrosu, M, Livrea, P, and Trojano, M.
Published: 2003

159. Earthy and Fresh Mushroom Off-Flavors in Wine: Optimized Remedial Treatments

Author: Behr, Marc, Cocco, E., Lenouvel, A., Guignard, Cedric, Evers, D., Behr, Marc, Cocco, E., Lenouvel, A., Guignard, Cedric, and Evers, D.
Abstract: info:eu-repo/semantics/published
Published: 2013

160. Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis

Author: Cossu, D., primary, Masala, S., additional, Frau, J., additional, Cocco, E., additional, Marrosu, M.G., additional, and Sechi, L.A., additional
Published: 2013
Full Text: View/download PDF

161. Switching from natalizumab to fingolimod

Author: Melis, M., primary, Cocco, E., additional, Sardu, C., additional, Frau, J., additional, Lorefice, L., additional, Coghe, G., additional, Fenu, G., additional, and Marrosu, M.G., additional
Published: 2013
Full Text: View/download PDF

162. Impact of apo E genotype on familial combined hyperlipemia (FCHL) expression

Author: Guardamagna, Ornella, Bondone, Claudia, Sacchetti, Carla, Gomez, A, Mercadante, G, Cocco, E, Allora, C, Bo, Mario, Bonardi, R, Bosso, S, and Restagno, G.
Subjects: allele variants, allele E4, apolipoprotein E, apoE gene, familial combined hyperlipidemia
Published: 2001

163. Impact of apo E grgenotype on Familial Combined Hyperlipidemia (FCHL) expression

Author: Guardamagna, O, Bondone, C, Sacchetti, C, Gomez, A. M., Mercadante, G, Cocco, E, Allora, C, Bo, Mario, Bonardi, R, Bosso, S, and Restagno, G.
Published: 2001

164. Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy

Author: Carboni, Nicoletta, Mura, M, Mercuri, Eugenio Maria, Marrosu, G, Manzi, Rc, Cocco, E, Nissardi, V, Isola, F, Mateddu, A, Solla, E, Maioli, Ma, Oppo, V, Piras, R, Marini, S, Lai, Carlo, Politano, L, Marrosu, Mg, Mercuri, Eugenio Maria (ORCID:0000-0002-9851-5365), Carboni, Nicoletta, Mura, M, Mercuri, Eugenio Maria, Marrosu, G, Manzi, Rc, Cocco, E, Nissardi, V, Isola, F, Mateddu, A, Solla, E, Maioli, Ma, Oppo, V, Piras, R, Marini, S, Lai, Carlo, Politano, L, Marrosu, Mg, and Mercuri, Eugenio Maria (ORCID:0000-0002-9851-5365)
Abstract: The following is a report on a large family with 5 males affected by the X-linked recessive form of Emery-Dreifuss muscular dystrophy with mutation in the STA gene. A detailed longitudinal cardiological evaluation and muscle imaging studies allowed for the assessment of intrafamilial variability of cardiac and muscle involvement. Long term cardiological follow up in the 5 affected males and in 7 female carriers revealed different degrees of severity, ranging from tachycardia-bradycardia syndrome and variable biatrial and left ventricle dilatation, to an episode of isolated symptomatic sustained ventricular tachycardia requiring a device implantation. Muscle imaging in the affected males showed involvement of the soleus and medial head of gastrocnemius on leg muscles and variable involvement on thigh muscles that have not been previously reported. In some cases, imaging showed clear signs of muscle involvement even when no overt signs of weakness could be detected during clinical examination.
Published: 2012

165. The influence of age at onset on the course of multiple sclerosis

Author: Liguori, M, Marrosu, Mg, De Robertis, F, Giuliani, F, Lai, M, Pugliatti, Maura, Cocco, E, and Livrea, P. Trojano M.
Published: 2000

166. The contribution of HLA to multiple sclerosis susceptibility in sardinian affected sibling pairs

Author: Marrosu, Mg, Fadda, E, Mancosu, C, Lai, M, Cocco, E, Pugliatti, Maura, and RI Cocco Eleonora/G 5064 2012
Published: 2000

167. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

Author: Martinelli, V, Cocco, E, Capra, R, Salemi, G, Gallo, P, Capobianco, M, Pesci, I, Ghezzi, A, Pozzilli, C, Lugaresi, A, Bellantonio, P, Amato, M, Grimaldi, L, Trojano, M, Mancardi, G, Bergamaschi, R, Gasperini, C, Rodegher, M, Straffi, L, Ponzio, M, Comi, G, Cavaletti, G, CAVALETTI, GUIDO ANGELO, Martinelli, V, Cocco, E, Capra, R, Salemi, G, Gallo, P, Capobianco, M, Pesci, I, Ghezzi, A, Pozzilli, C, Lugaresi, A, Bellantonio, P, Amato, M, Grimaldi, L, Trojano, M, Mancardi, G, Bergamaschi, R, Gasperini, C, Rodegher, M, Straffi, L, Ponzio, M, Comi, G, Cavaletti, G, and CAVALETTI, GUIDO ANGELO
Abstract: Objectives: To evaluate the incidence and dose-dependency of mitoxantrone (MTX)-associated acute myelocytic leukemia (AML) in the network of Italian multiple sclerosis (MS) clinics. Methods: We performed a multicenter retrospective cohort study of patients treated with MTX in MS centers under the Italian national health care system between 1998 and 2008. Demographic, disease, treatment, and follow-up information were collected using hospital records. Results: Data were available for 3,220 patients (63% women) from 40 Italian centers. Follow-up (mean±SD) was 49±29 months (range 12-140 months).Weobserved 30 cases of AML (incidence 0.93% [95% confidence interval 0.60%-1.26%]). The mean cumulative dose was higher in patients with AML (78 vs 65 mg/m2, p=0.028). The median interval from the start of therapy to AML diagnosis was longer than expected at 33 months (range 13-84 months); 8 patients (27%) developed AML 4 years or more after the first MTX infusion. The rate of mortality associated with AML was 37%. Conclusions: This higher than expected risk of AML and related mortality requires that treatment decisions must be made jointly between clinicians and patients who understand their prognosis, treatment options, and treatment-related risks. The now large exposed MS population must be monitored for hematologic abnormalities for at least 6 years from the end of therapy, to ensure the rapid actions needed for early diagnosis and treatment of AML. Copyright © 2011 by AAN Enterprises, Inc.
Published: 2011

168. FRI-389 - Oral Bacterial Activity is Significantly Associated with Autoimmune Liver Diseases and it Could be Involved in their Pathogenesis Mechanisms

Author: Figorilli, F., Orrù, G., Onali, S., Salustro, C., Cappellini, S., Cocco, E., Fais, S., Melis, M., Gilardi, A., Secci, L., Casu, S., Littera, S., and Chessa, L.
Published: 2016
Full Text: View/download PDF

169. HLA contribute to multiple sclerosis susceptibility in Sardinian affected sib pairs

Author: Marrosu, Mg, Schirru, L, Fadda, E, Ilaria, P, Solla, E, Cristina, M, Mancosu, C, Lai, M, Cocco, E, Pugliatti, Maura, and Sotgiu, S.
Published: 1999

170. Parent-of-origin effect of HLA genes in Sardinian multiple sclerosis

Author: Marrosu, Mg, Murru, R, Lai, M, Murru, Mr, Costa, G, Cocco, E, Sotgiu, S, Pugliatti, Maura, and Cucca, F.
Published: 1999

171. Occurrence and distribution of the mycotoxin-producing Fusarium species isolated from winter wheat in Luxemburg in 2007 and 2008

Author: UCL - SST/ELI/ELIM - Applied Microbiology, Giraud, F., Pasquali, M., Vrancken, C, Brochot, E., Cocco, E., Contal, S., Munaut, Françoise, El Jarroudi, M., Hoffman, L., Delfosse, Ph., Bohn, T., Third Symposium mycotoxins : threats and risk management, UCL - SST/ELI/ELIM - Applied Microbiology, Giraud, F., Pasquali, M., Vrancken, C, Brochot, E., Cocco, E., Contal, S., Munaut, Françoise, El Jarroudi, M., Hoffman, L., Delfosse, Ph., Bohn, T., and Third Symposium mycotoxins : threats and risk management
Published: 2009

172. Fusarioses sur blé d’hiver au Grand-Duché de Luxembourg. Premiers résultats d’une enquête commencée en 2007 sur l’identification des agents de la fusariose.

Author: UCL - SST/ELI/ELIM - Applied Microbiology, Giraud, F., Pasquali, M., Vrancken, C., Cocco, E., Munaut, Françoise, El Jarroudi, M., Bohn, T., Hoffmann, L., Delfosse, Ph., UCL - SST/ELI/ELIM - Applied Microbiology, Giraud, F., Pasquali, M., Vrancken, C., Cocco, E., Munaut, Françoise, El Jarroudi, M., Bohn, T., Hoffmann, L., and Delfosse, Ph.
Published: 2009

173. Earthy and Fresh Mushroom Off-Flavors in Wine: Optimized Remedial Treatments

Author: Behr, M., primary, Cocco, E., additional, Lenouvel, A., additional, Guignard, C., additional, and Evers, D., additional
Published: 2013
Full Text: View/download PDF

174. Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

Author: Bellone, S, primary, Tassi, R, additional, Betti, M, additional, English, D, additional, Cocco, E, additional, Gasparrini, S, additional, Bortolomai, I, additional, Black, J D, additional, Todeschini, P, additional, Romani, C, additional, Ravaggi, A, additional, Bignotti, E, additional, Bandiera, E, additional, Zanotti, L, additional, Pecorelli, S, additional, Ardighieri, L, additional, Falchetti, M, additional, Donzelli, C, additional, Siegel, E R, additional, Azodi, M, additional, Silasi, D-A, additional, Ratner, E, additional, Schwartz, P E, additional, Rutherford, T J, additional, and Santin, A D, additional
Published: 2013
Full Text: View/download PDF

175. Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical features

Author: Frau, J, primary, Cossu, D, additional, Coghe, G, additional, Lorefice, L, additional, Fenu, G, additional, Melis, M, additional, Paccagnini, D, additional, Sardu, C, additional, Murru, MR, additional, Tranquilli, S, additional, Marrosu, MG, additional, Sechi, LA, additional, and Cocco, E, additional
Published: 2013
Full Text: View/download PDF

176. Anticipation of multiple sclerosis (MS) onset in children of parent/child pairs from Italian MS multiplex families

Author: Trojano, M, Liguori, M, Marrosu, Mg, Lai, M, Cocco, E, Pugliatti, Maura, DE ROBERTIS, F, Avolio, C, Giuliani, F, Paolicelli, D, and Livrea, P.
Published: 1996

177. T Regulatories (Tregs) and Suppressor Cytokine mRNA (IL-10, TGF , IL-27) Increase after Alemtuzumab in MS: First 24 Month Immunological Report on 323 and 324 Genzyme Trials (P02.088)

Author: De Mercanti, S., primary, Cucci, A., additional, Viglietta, E., additional, Giai Via, A., additional, Taverna, D., additional, Cimino, D., additional, Rolla, S., additional, Bardina, V., additional, Novelli, F., additional, Vargas, J., additional, Gibbin, M., additional, Piazza, F., additional, Vladic, A., additional, Brinar, V., additional, Habek, M., additional, Cocco, E., additional, Annovazzi, P., additional, Horakova, D., additional, Kovarova, I., additional, Clerico, M., additional, and Durelli, L., additional
Published: 2012
Full Text: View/download PDF

178. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy

Author: Bellone, S, primary, Roque, D, additional, Cocco, E, additional, Gasparrini, S, additional, Bortolomai, I, additional, Buza, N, additional, Abu-Khalaf, M, additional, Silasi, D-A, additional, Ratner, E, additional, Azodi, M, additional, Schwartz, P E, additional, Rutherford, T J, additional, Pecorelli, S, additional, and Santin, A D, additional
Published: 2012
Full Text: View/download PDF

179. Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression

Author: Roque, D., primary, Carrara, L., additional, Cocco, E., additional, Guzzo, F., additional, Sartori, E., additional, Bellone, S., additional, Pecorelli, S., additional, Schwartz, P., additional, Rutherford, T., additional, and Santin, A., additional
Published: 2012
Full Text: View/download PDF

180. Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation

Author: Capobianco, Marco, primary, Motuzova, Y., additional, Frau, J., additional, Cocco, E., additional, Mamusa, E., additional, Marrosu, M. G., additional, and Bertolotto, A., additional
Published: 2011
Full Text: View/download PDF

181. Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab

Author: Todeschini, P, primary, Cocco, E, additional, Bellone, S, additional, Varughese, J, additional, Lin, K, additional, Carrara, L, additional, Guzzo, F, additional, Buza, N, additional, Hui, P, additional, Silasi, D-A, additional, Ratner, E, additional, Azodi, M, additional, Schwartz, P E, additional, Rutherford, T J, additional, Pecorelli, S, additional, and Santin, A D, additional
Published: 2011
Full Text: View/download PDF

182. Determination of atrazine and degradation products in Luxembourgish drinking water: origin and fate of potential endocrine-disrupting pesticides

Author: Bohn, T., primary, Cocco, E., additional, Gourdol, L., additional, Guignard, C., additional, and Hoffmann, L., additional
Published: 2011
Full Text: View/download PDF

183. The effect of intraperitoneal administration of clostridium perfringens enterotoxin on chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice.

Author: Varughese, J., primary, Casagrande, F., additional, Cocco, E., additional, Bellone, S., additional, Richter, C. E., additional, Bellone, M., additional, Todeschini, P., additional, Carrara, L., additional, Guzzo, F., additional, Siegel, E., additional, Silasi, D., additional, Azodi, M., additional, Rutherford, T., additional, Pecorelli, S. L., additional, Schwartz, P. E., additional, and Santin, A., additional
Published: 2011
Full Text: View/download PDF

184. Uterine serous papillary carcinomas overexpress human trophoblast cell surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody

Author: Santin, A., primary, Bellone, S., additional, Varughese, J., additional, Cocco, E., additional, Ratner, E., additional, Silasi, D., additional, Rutherford, T., additional, Schwartz, P., additional, Azodi, M., additional, and Pecorelli, S., additional
Published: 2011
Full Text: View/download PDF

185. Divergent Effect of Cobalt and Beryllium Salts on the Fate of Peripheral Blood Monocytes and T Lymphocytes

Author: Paladini, F., primary, Cocco, E., additional, Potolicchio, I., additional, Fazekasova, H., additional, Lombardi, G., additional, Fiorillo, M. T., additional, and Sorrentino, R., additional
Published: 2010
Full Text: View/download PDF

186. hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma

Author: Cocco, E, primary, Hu, Z, additional, Richter, C E, additional, Bellone, S, additional, Casagrande, F, additional, Bellone, M, additional, Todeschini, P, additional, Krikun, G, additional, Silasi, D-A, additional, Azodi, M, additional, Schwartz, P E, additional, Rutherford, T J, additional, Buza, N, additional, Pecorelli, S, additional, Lockwood, C J, additional, and Santin, A D, additional
Published: 2010
Full Text: View/download PDF

187. EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201) in chemotherapy-resistant ovarian cancer cell lines.

Author: Richter, C. E., primary, Cocco, E., additional, Bellone, S., additional, Casagrande, F., additional, Bellone, M., additional, Silasi, D., additional, Azodi, M., additional, Schwartz, P. E., additional, Rutherford, T., additional, and Santin, A., additional
Published: 2010
Full Text: View/download PDF

188. Genetic Fusarium chemotyping as a useful tool for predicting nivalenol contamination in winter wheat

Author: Pasquali, M., primary, Giraud, F., additional, Brochot, C., additional, Cocco, E., additional, Hoffmann, L., additional, and Bohn, T., additional
Published: 2010
Full Text: View/download PDF

189. In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma

Author: El-Sahwi, K, primary, Bellone, S, additional, Cocco, E, additional, Cargnelutti, M, additional, Casagrande, F, additional, Bellone, M, additional, Abu-Khalaf, M, additional, Buza, N, additional, Tavassoli, F A, additional, Hui, P, additional, Silasi, D-A, additional, Azodi, M, additional, Schwartz, P E, additional, Rutherford, T J, additional, Pecorelli, S, additional, and Santin, A D, additional
Published: 2009
Full Text: View/download PDF

190. FP39-WE-05 High incidence of acute leukaemia in multiple sclerosis patients treated with mitoxantrone: a retrospective multicentre Italian study

Author: Martinelli, V., primary, Capra, R., additional, Gasperini, C., additional, Cocco, E., additional, Bellantonio, P., additional, Pesci, I., additional, Bertolotto, A., additional, Gallo, P., additional, Amato, M.P., additional, Ghezzi, A., additional, Grimaldi, L., additional, Lugaresi, A., additional, Mancardi, G., additional, Bergamaschi, R., additional, Ponzio, M., additional, Pozzilli, C., additional, Salemi, G., additional, Trojano, M., additional, Rodegher, M.E., additional, Straffi, L., additional, and Comi, G., additional
Published: 2009
Full Text: View/download PDF

191. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population

Author: Cocco, E, primary, Sardu, C, additional, Murru, R, additional, Frau, J, additional, Lorefice, L, additional, Mamusa, E, additional, Contu, P, additional, and Marrosu, MG, additional
Published: 2009
Full Text: View/download PDF

192. Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer

Author: Cocco, E, primary, Bellone, S, additional, El-Sahwi, K, additional, Cargnelutti, M, additional, Casagrande, F, additional, Buza, N, additional, Tavassoli, F A, additional, Siegel, E R, additional, Visintin, I, additional, Ratner, E, additional, Silasi, D-A, additional, Azodi, M, additional, Schwartz, P E, additional, Rutherford, T J, additional, Pecorelli, S, additional, and Santin, A D, additional
Published: 2009
Full Text: View/download PDF

193. Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia

Author: Zoledziewska, M, primary, Costa, G, additional, Pitzalis, M, additional, Cocco, E, additional, Melis, C, additional, Moi, L, additional, Zavattari, P, additional, Murru, R, additional, Lampis, R, additional, Morelli, L, additional, Poddie, F, additional, Frongia, P, additional, Pusceddu, P, additional, Bajorek, M, additional, Marras, A, additional, Satta, A M, additional, Chessa, A, additional, Pugliatti, M, additional, Sotgiu, S, additional, Whalen, M B, additional, Rosati, G, additional, Cucca, F, additional, and Marrosu, M G, additional
Published: 2008
Full Text: View/download PDF

194. Juvenile Multiple Sclerosis Similar to Type I Diabetes Mellitus has a Seasonality of Month of Birth which Differs from that in the General Population

Author: Lewy, H., primary, Rotstein, Α, additional, Kahana, E., additional, Marrosu, M.G., additional, Cocco, E., additional, and Laron, Z., additional
Published: 2008
Full Text: View/download PDF

195. Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis

Author: Cocco, E., primary, Marchi, P., additional, Sardu, C., additional, Russo, P., additional, Paolillo, A., additional, Mascia, MG, additional, Solla, M., additional, Frau, J., additional, Lorefice, L., additional, Massole, S., additional, Floris, G., additional, and Marrosu, MG, additional
Published: 2007
Full Text: View/download PDF

196. Vagal nerve stimulation improves cerebellar tremor and dysphagia in multiple sclerosis

Author: Marrosu, F., primary, Maleci, A., additional, Cocco, E., additional, Puligheddu, M., additional, Barberini, L., additional, and Marrosu, M.G., additional
Published: 2007
Full Text: View/download PDF

197. Familial effects on the clinical course of multiple sclerosis

Author: Hensiek, A. E., primary, Seaman, S. R., additional, Barcellos, L. F., additional, Oturai, A., additional, Eraksoi, M., additional, Cocco, E., additional, Vecsei, L., additional, Stewart, G., additional, Dubois, B., additional, Bellman-Strobl, J., additional, Leone, M., additional, Andersen, O., additional, Bencsik, K., additional, Booth, D., additional, Celius, E. G., additional, Harbo, H. F., additional, Hauser, S. L., additional, Heard, R., additional, Hillert, J., additional, Myhr, K. -M., additional, Marrosu, M. G., additional, Oksenberg, J. R., additional, Rajda, C., additional, Sawcer, S. J., additional, Sorensen, P. S., additional, Zipp, F., additional, and Compston, D.A.S., additional
Published: 2007
Full Text: View/download PDF

198. HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin

Author: Restagno, G, primary, Lombardo, F, additional, Ghiglione, P, additional, Calvo, A, additional, Cocco, E, additional, Sbaiz, L, additional, Mutani, R, additional, and Chio, A, additional
Published: 2006
Full Text: View/download PDF

199. Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation

Author: Marrosu, M. G., primary, Floris, G., additional, Costa, G., additional, Schirru, L., additional, Spinicci, G., additional, Cherchi, M. V., additional, Mura, M., additional, Mascia, M. G., additional, and Cocco, E., additional
Published: 2006
Full Text: View/download PDF

200. Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population

Author: Marrosu, M. G., primary, Cocco, E., additional, Costa, G., additional, Murru, M. R., additional, Mancosu, C., additional, Murru, R., additional, Lai, M., additional, Sardu, C., additional, and Contu, P., additional
Published: 2005
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

961 results on '"Cocco, E."'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources